The Trump administration’s plans to lower prices are just Biden-era retreads. Unfortunately, they’re just plans, with no expected follow-through.
prescription drugs
Republicans Scramble for Health Care Ideas as Obamacare Deadline Looms
Next week, massive premium increases get locked in. The GOP has shown no interest in stopping it, or preventing any other increases in health care costs.
Meet the Connectors
Middlemen, our economy’s most shadowy characters, sit in between buyers and sellers and get rich in the process. It can even be a matter of life or death.
‘TrumpRx’ Is Another Pretend Solution for High Drug Prices
The proposed government website will just refer people to the drug companies, which use direct-to-consumer pricing to distract from continued high profits.
Trump’s Order to Cut Drug Prices Would Raise Drug Prices
The so-called ‘pill penalty’ fix is a corporate favor designed to increase the period where prescriptions are immune from price negotiations.
New Jersey Continues to Add Abortion Protections
State reproductive rights advocates view a stockpile as one of a number of ways to protect access.
The Case Without a Judge
The logical, absurd end point of Donald Trump’s government smash-and-grab
L.A. Times Owner Has Financial Motivations for Boosting RFK Jr.
Dr. Patrick Soon-Shiong’s biotech firm is preparing three applications needing approval from the Food and Drug Administration.
Trump’s Big Choice on Drug Prices
By following through on Biden’s Medicare price negotiation program, he can take credit for prescription reductions. But Big Pharma doesn’t want that to happen.
Congressional Drug-Pricing Reforms Upend Trump’s Strategy
He has typically allied with Big Pharma, pointing fingers at pharmacy benefit managers. But a bipartisan agreement could do away with that gambit.

